United States biopharma AbbVie to buy Botox maker Allergan for $63 billion

Abbvie is the maker of the blockbuster immune disorder treatment Humira

The deal is the second mega merger this year, after January saw Bristol-Myers Squibb put in a $74 billion bid for Celgene.

Including Allergan's debts, the entire deal is estimated to be worth more than $83 billion.

Revance has a market value of $550 million, and the stock jumped 5% yesterday after the AbbVie-Allergan deal was announced.

The offer represents a 45 per cent premium over Monday's share price of Irish-registered Allergan, whose management recommended the operation to shareholders.

"The price tag caused heartburn on Wall Street, and AbbVie had its worst day of trading since it was spun off from former parent Abbott Laboratories". And although it brought in nearly $20 billion in revenue previous year, Humira's lower-priced competitors are already on sale in Europe and headed for the U.S.in 2023.


Allergan's chief executive officer, Brent Saunders, said: "With 2019 annual combined revenue of approximately $US48 billion, scale in more than 175 countries, an industry-leading R&D pipeline and robust cash flows, our combined company will have the opportunity to make even bigger contributions to global health than either can alone". Allergan's shares have lost around half their value since then. Its future rate will rise to only 13%, the company said. A USA corporate tax overhaul under the Trump administration, which helped companies bring back revenue earned overseas, also helped, he said. Mr Gonzalez said on the call that he intends to stay with the company at least through Humira's loss of exclusivity in the US. Allergan shares rose 31 percent in premarket trading Tuesday to $170.25 per share while AbbVie dropped eight percent to $72.

Shares of AbbVie are down 16% over the past year and shares of Allergan have fallen 24%, amid declining sales growth over the past three quarters and the failure of an experimental depression drug in March.

The transaction is expected to add 10% to adjusted earnings per share over the first full year following the close, the companies said.

Two Allergan directors, including Mr Saunders, will join AbbVie's board after the purchase is completed, according to the statement.

Morgan Stanley & Co. acted as AbbVie's financial adviser and Kirkland & Ellis LLP and McCann FitzGerald were legal advisers.

Related:

Comments

Latest news

Google Maps gets Stay Safer mode
She was a little skeptical but saw other cars in front of her, so she continued following her Global Positioning System . We encourage all drivers to follow local laws, stay attentive, and use their best judgment while driving".

UK to not join Trump in war against Iran: UK Foreign secretary
But Russian Deputy Foreign Minister Sergei Ryabkov said Moscow and its partners will take steps to counter possible new sanctions. The United States has also blamed Iran for attacks on oil tankers in the Gulf region in May and June.

13-Year-Old Charged in Possible Hate Attack on New Jersey Mother
In maintaining with Santiago, the assistant vice predominant of the varsity acknowledged he'd simply forgotten to name her. A Passaic County mother was beaten unconscious by her son's bully in what she claims was an attack motivated by racism.

Angela Merkel shakes AGAIN during official ceremony
She has a reputation for remarkable stamina - during intensive late-night discussions at European Union summits, for example. Merkel's office wouldn't comment on the cause or otherwise elaborate.

Amazon adds "can't-miss" Prime Day Concert, new Prime Day deals
In just three years, it's quickly grown to become the #3 biggest shopping event on RedFlagDeals after Black Friday and Boxing Day. Unlike Prime Day , which requires an active membership to Amazon Prime, there is no requirement to take part in the eBay sales.

Other news